MedTrace Logo

Transcriptomic Study of IBD-associated Colorectal Cancer

NCT05060770 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2021-10-07

No results posted yet for this study

Summary

Chronic inflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer (CRC) in historical cohorts. The pathways of oncogenesis of these CRCs, which are very different clinically from de novo CRCs, are currently unknown. The aim of our work is to identify specific molecular signatures of CRC occurring in the setting of IBD.

Conditions

  • Colorectal Cancer, Genetics of

Interventions

GENETIC

transcriptomic analysis

transcriptomic analysis on preserved tumor tissue

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2021-01-01
Completion
2021-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05060770 on ClinicalTrials.gov